APO Research
Talk to an analyst

APO RESEARCH · REPORT

Male Infertility Treatment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Male Infertility Treatment Market Outlook and Growth Opportunities 2026

19 December 2025207 pages

Choose your research edition.

Industry ResearchMale Infertility Treatment Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Male Infertility Treatment Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Male Infertility Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Male Infertility Treatment Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Male Infertility Treatment Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Male Infertility Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Male Infertility Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Male Infertility Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Male Infertility Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Male Infertility Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Male Infertility Treatment market include Zhejiang Xianju Pharmaceutical Co.,Ltd., Church & Dwight, Livzon Pharmaceutical Group Inc., Eli Lilly and Company, GeneScience Pharmaceuticals Co., Ltd., Bayer, Bristol Myers Squibb, SCSA diagnostics and Merck Serono, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Male Infertility Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Male Infertility Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Male Infertility Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Male Infertility Treatment market.

Male Infertility Treatment Segment by Company

Zhejiang Xianju Pharmaceutical Co.,Ltd.

Church & Dwight

Livzon Pharmaceutical Group Inc.

Eli Lilly and Company

GeneScience Pharmaceuticals Co., Ltd.

Bayer

Bristol Myers Squibb

SCSA diagnostics

Merck Serono

Intas Pharma

Intas Biopharmaceuticals

Halotech DNA

Cadila

Aytu BioScience

ASKA Pharmaceutical Co., Ltd.

Andrology Solutions

Abeona Therapeutics Inc.

Male Infertility Treatment Segment by Type

Oxidative Stress Analysis

Microscopic Examination

Sperm Agglutination

Sperm Penetration Assay

DNA Fragmentation Technique

Computer Assisted Semen Analysis

Male Infertility Treatment Segment by Application

Hospitals

Clinics

Others

Male Infertility Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Male Infertility Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Male Infertility Treatment key companies, revenue, market share, and recent developments.

3. To split the Male Infertility Treatment breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Male Infertility Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Male Infertility Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Male Infertility Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Male Infertility Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Male Infertility Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Male Infertility Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Male Infertility Treatment industry.

Chapter 3: Detailed analysis of Male Infertility Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Male Infertility Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Male Infertility Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Male Infertility Treatment Industry Trends Table 2. Male Infertility Treatment Industry Drivers Table 3. Male Infertility Treatment Industry Opportunities and Challenges Table 4. Male Infertility Treatment Industry Restraints Table 5. Global Male Infertility Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Male Infertility Treatment Revenue Share by Company (2021-2026) Table 7. Global Male Infertility Treatment Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Male Infertility Treatment Key Company Manufacturing Base & Headquarters Table 9. Global Male Infertility Treatment Company, Product Type & Application Table 10. Global Male Infertility Treatment Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Male Infertility Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Oxidative Stress Analysis Table 15. Significant Companies of Microscopic Examination Table 16. Significant Companies of Sperm Agglutination Table 17. Significant Companies of Sperm Penetration Assay Table 18. Significant Companies of DNA Fragmentation Technique Table 19. Significant Companies of Computer Assisted Semen Analysis Table 20. Global Male Infertility Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Male Infertility Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Male Infertility Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Male Infertility Treatment Sales Value Share by Type (2021-2026) Table 24. Global Male Infertility Treatment Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Hospitals Table 26. Significant Companies of Clinics Table 27. Significant Companies of Others Table 28. Global Male Infertility Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Male Infertility Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Male Infertility Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Male Infertility Treatment Sales Value Share by Application (2021-2026) Table 32. Global Male Infertility Treatment Sales Value Share by Application (2027-2032) Table 33. Global Male Infertility Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Male Infertility Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Male Infertility Treatment Sales Value Share by Region (2021-2026) Table 36. Global Male Infertility Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Male Infertility Treatment Sales Value Share by Region (2027-2032) Table 38. Global Male Infertility Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Male Infertility Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Male Infertility Treatment Sales Value Market Share by Country (2021-2026) Table 41. Global Male Infertility Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Male Infertility Treatment Sales Value Market Share by Country (2027-2032) Table 43. Zhejiang Xianju Pharmaceutical Co.,Ltd. Company Information Table 44. Zhejiang Xianju Pharmaceutical Co.,Ltd. Business Overview Table 45. Zhejiang Xianju Pharmaceutical Co.,Ltd. Male Infertility Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Zhejiang Xianju Pharmaceutical Co.,Ltd. Male Infertility Treatment Product Portfolio Table 47. Zhejiang Xianju Pharmaceutical Co.,Ltd. Recent Development Table 48. Church & Dwight Company Information Table 49. Church & Dwight Business Overview Table 50. Church & Dwight Male Infertility Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Church & Dwight Male Infertility Treatment Product Portfolio Table 52. Church & Dwight Recent Development Table 53. Livzon Pharmaceutical Group Inc. Company Information Table 54. Livzon Pharmaceutical Group Inc. Business Overview Table 55. Livzon Pharmaceutical Group Inc. Male Infertility Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Livzon Pharmaceutical Group Inc. Male Infertility Treatment Product Portfolio Table 57. Livzon Pharmaceutical Group Inc. Recent Development Table 58. Eli Lilly and Company Company Information Table 59. Eli Lilly and Company Business Overview Table 60. Eli Lilly and Company Male Infertility Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Eli Lilly and Company Male Infertility Treatment Product Portfolio Table 62. Eli Lilly and Company Recent Development Table 63. GeneScience Pharmaceuticals Co., Ltd. Company Information Table 64. GeneScience Pharmaceuticals Co., Ltd. Business Overview Table 65. GeneScience Pharmaceuticals Co., Ltd. Male Infertility Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. GeneScience Pharmaceuticals Co., Ltd. Male Infertility Treatment Product Portfolio Table 67. GeneScience Pharmaceuticals Co., Ltd. Recent Development Table 68. Bayer Company Information Table 69. Bayer Business Overview Table 70. Bayer Male Infertility Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Bayer Male Infertility Treatment Product Portfolio Table 72. Bayer Recent Development Table 73. Bristol Myers Squibb Company Information Table 74. Bristol Myers Squibb Business Overview Table 75. Bristol Myers Squibb Male Infertility Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Bristol Myers Squibb Male Infertility Treatment Product Portfolio Table 77. Bristol Myers Squibb Recent Development Table 78. SCSA diagnostics Company Information Table 79. SCSA diagnostics Business Overview Table 80. SCSA diagnostics Male Infertility Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. SCSA diagnostics Male Infertility Treatment Product Portfolio Table 82. SCSA diagnostics Recent Development Table 83. Merck Serono Company Information Table 84. Merck Serono Business Overview Table 85. Merck Serono Male Infertility Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Merck Serono Male Infertility Treatment Product Portfolio Table 87. Merck Serono Recent Development Table 88. Intas Pharma Company Information Table 89. Intas Pharma Business Overview Table 90. Intas Pharma Male Infertility Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Intas Pharma Male Infertility Treatment Product Portfolio Table 92. Intas Pharma Recent Development Table 93. Intas Biopharmaceuticals Company Information Table 94. Intas Biopharmaceuticals Business Overview Table 95. Intas Biopharmaceuticals Male Infertility Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Intas Biopharmaceuticals Male Infertility Treatment Product Portfolio Table 97. Intas Biopharmaceuticals Recent Development Table 98. Halotech DNA Company Information Table 99. Halotech DNA Business Overview Table 100. Halotech DNA Male Infertility Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Halotech DNA Male Infertility Treatment Product Portfolio Table 102. Halotech DNA Recent Development Table 103. Cadila Company Information Table 104. Cadila Business Overview Table 105. Cadila Male Infertility Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Cadila Male Infertility Treatment Product Portfolio Table 107. Cadila Recent Development Table 108. Aytu BioScience Company Information Table 109. Aytu BioScience Business Overview Table 110. Aytu BioScience Male Infertility Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Aytu BioScience Male Infertility Treatment Product Portfolio Table 112. Aytu BioScience Recent Development Table 113. ASKA Pharmaceutical Co., Ltd. Company Information Table 114. ASKA Pharmaceutical Co., Ltd. Business Overview Table 115. ASKA Pharmaceutical Co., Ltd. Male Infertility Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. ASKA Pharmaceutical Co., Ltd. Male Infertility Treatment Product Portfolio Table 117. ASKA Pharmaceutical Co., Ltd. Recent Development Table 118. Andrology Solutions Company Information Table 119. Andrology Solutions Business Overview Table 120. Andrology Solutions Male Infertility Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Andrology Solutions Male Infertility Treatment Product Portfolio Table 122. Andrology Solutions Recent Development Table 123. Abeona Therapeutics Inc. Company Information Table 124. Abeona Therapeutics Inc. Business Overview Table 125. Abeona Therapeutics Inc. Male Infertility Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Abeona Therapeutics Inc. Male Infertility Treatment Product Portfolio Table 127. Abeona Therapeutics Inc. Recent Development Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Male Infertility Treatment Product Image Figure 2. Global Male Infertility Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Male Infertility Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Male Infertility Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Oxidative Stress Analysis Image Figure 8. Microscopic Examination Image Figure 9. Sperm Agglutination Image Figure 10. Sperm Penetration Assay Image Figure 11. DNA Fragmentation Technique Image Figure 12. Computer Assisted Semen Analysis Image Figure 13. Global Male Infertility Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Male Infertility Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Male Infertility Treatment Sales Value Share by Type (2021-2032) Figure 16. Hospitals Image Figure 17. Clinics Image Figure 18. Others Image Figure 19. Global Male Infertility Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Male Infertility Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Male Infertility Treatment Sales Value Share by Application (2021-2032) Figure 22. Global Male Infertility Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Male Infertility Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Male Infertility Treatment Sales Value (2021-2032) & (US$ Million) Figure 25. North America Male Infertility Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Male Infertility Treatment Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Male Infertility Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Male Infertility Treatment Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Male Infertility Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Male Infertility Treatment Sales Value (2021-2032) & (US$ Million) Figure 31. South America Male Infertility Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Male Infertility Treatment Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Male Infertility Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Male Infertility Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Oxidative Stress Analysis
  • Microscopic Examination
  • Sperm Agglutination
  • Sperm Penetration Assay
  • DNA Fragmentation Technique
  • Computer Assisted Semen Analysis
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Zhejiang Xianju Pharmaceutical Co.,Ltd.
  • Church & Dwight
  • Livzon Pharmaceutical Group Inc.
  • Eli Lilly and Company
  • GeneScience Pharmaceuticals Co., Ltd.
  • Bayer
  • Bristol Myers Squibb
  • SCSA diagnostics
  • Merck Serono
  • Intas Pharma
  • Intas Biopharmaceuticals
  • Halotech DNA
  • Cadila
  • Aytu BioScience
  • ASKA Pharmaceutical Co., Ltd.
  • Andrology Solutions
  • Abeona Therapeutics Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Male Infertility Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Male Infertility Treatment Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Male Infertility Treatment Market Dynamics
  1. 2.1 Male Infertility Treatment Industry Trends
  2. 2.2 Male Infertility Treatment Industry Drivers
  3. 2.3 Male Infertility Treatment Industry Opportunities and Challenges
  4. 2.4 Male Infertility Treatment Industry Restraints
3 Male Infertility Treatment Market by Company
  1. 3.1 Global Male Infertility Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Male Infertility Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Male Infertility Treatment Company Ranking (2024-2026)
  4. 3.4 Global Male Infertility Treatment Company Manufacturing Base and Headquarters
  5. 3.5 Global Male Infertility Treatment Company Product Type and Application
  6. 3.6 Global Male Infertility Treatment Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Male Infertility Treatment Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Male Infertility Treatment Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Male Infertility Treatment Market by Type
  1. 4.1 Male Infertility Treatment Type Introduction
  2. 4.1.1 Oxidative Stress Analysis
  3. 4.1.2 Microscopic Examination
  4. 4.1.3 Sperm Agglutination
  5. 4.1.4 Sperm Penetration Assay
  6. 4.1.5 DNA Fragmentation Technique
  7. 4.1.6 Computer Assisted Semen Analysis
  8. 4.2 Global Male Infertility Treatment Sales Value by Type
  9. 4.2.1 Global Male Infertility Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Male Infertility Treatment Sales Value by Type (2021-2032)
  11. 4.2.3 Global Male Infertility Treatment Sales Value Share by Type (2021-2032)
5 Male Infertility Treatment Market by Application
  1. 5.1 Male Infertility Treatment Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Male Infertility Treatment Sales Value by Application
  6. 5.2.1 Global Male Infertility Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Male Infertility Treatment Sales Value by Application (2021-2032)
  8. 5.2.3 Global Male Infertility Treatment Sales Value Share by Application (2021-2032)
6 Male Infertility Treatment Regional Value Analysis
  1. 6.1 Global Male Infertility Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Male Infertility Treatment Sales Value by Region (2021-2032)
  3. 6.2.1 Global Male Infertility Treatment Sales Value by Region: 2021-2026
  4. 6.2.2 Global Male Infertility Treatment Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Male Infertility Treatment Sales Value (2021-2032)
  7. 6.3.2 North America Male Infertility Treatment Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Male Infertility Treatment Sales Value (2021-2032)
  10. 6.4.2 Europe Male Infertility Treatment Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Male Infertility Treatment Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Male Infertility Treatment Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Male Infertility Treatment Sales Value (2021-2032)
  16. 6.6.2 South America Male Infertility Treatment Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Male Infertility Treatment Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Male Infertility Treatment Sales Value Share by Country, 2025 VS 2032
7 Male Infertility Treatment Country-level Value Analysis
  1. 7.1 Global Male Infertility Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Male Infertility Treatment Sales Value by Country (2021-2032)
  3. 7.2.1 Global Male Infertility Treatment Sales Value by Country (2021-2026)
  4. 7.2.2 Global Male Infertility Treatment Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Male Infertility Treatment Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Male Infertility Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Male Infertility Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Xianju Pharmaceutical Co.,Ltd.
  2. 8.1.1 Zhejiang Xianju Pharmaceutical Co.,Ltd. Company Information
  3. 8.1.2 Zhejiang Xianju Pharmaceutical Co.,Ltd. Business Overview
  4. 8.1.3 Zhejiang Xianju Pharmaceutical Co.,Ltd. Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Xianju Pharmaceutical Co.,Ltd. Male Infertility Treatment Product Portfolio
  6. 8.1.5 Zhejiang Xianju Pharmaceutical Co.,Ltd. Recent Developments
  7. 8.2 Church & Dwight
  8. 8.2.1 Church & Dwight Company Information
  9. 8.2.2 Church & Dwight Business Overview
  10. 8.2.3 Church & Dwight Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Church & Dwight Male Infertility Treatment Product Portfolio
  12. 8.2.5 Church & Dwight Recent Developments
  13. 8.3 Livzon Pharmaceutical Group Inc.
  14. 8.3.1 Livzon Pharmaceutical Group Inc. Company Information
  15. 8.3.2 Livzon Pharmaceutical Group Inc. Business Overview
  16. 8.3.3 Livzon Pharmaceutical Group Inc. Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Livzon Pharmaceutical Group Inc. Male Infertility Treatment Product Portfolio
  18. 8.3.5 Livzon Pharmaceutical Group Inc. Recent Developments
  19. 8.4 Eli Lilly and Company
  20. 8.4.1 Eli Lilly and Company Company Information
  21. 8.4.2 Eli Lilly and Company Business Overview
  22. 8.4.3 Eli Lilly and Company Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Eli Lilly and Company Male Infertility Treatment Product Portfolio
  24. 8.4.5 Eli Lilly and Company Recent Developments
  25. 8.5 GeneScience Pharmaceuticals Co., Ltd.
  26. 8.5.1 GeneScience Pharmaceuticals Co., Ltd. Company Information
  27. 8.5.2 GeneScience Pharmaceuticals Co., Ltd. Business Overview
  28. 8.5.3 GeneScience Pharmaceuticals Co., Ltd. Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GeneScience Pharmaceuticals Co., Ltd. Male Infertility Treatment Product Portfolio
  30. 8.5.5 GeneScience Pharmaceuticals Co., Ltd. Recent Developments
  31. 8.6 Bayer
  32. 8.6.1 Bayer Company Information
  33. 8.6.2 Bayer Business Overview
  34. 8.6.3 Bayer Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bayer Male Infertility Treatment Product Portfolio
  36. 8.6.5 Bayer Recent Developments
  37. 8.7 Bristol Myers Squibb
  38. 8.7.1 Bristol Myers Squibb Company Information
  39. 8.7.2 Bristol Myers Squibb Business Overview
  40. 8.7.3 Bristol Myers Squibb Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bristol Myers Squibb Male Infertility Treatment Product Portfolio
  42. 8.7.5 Bristol Myers Squibb Recent Developments
  43. 8.8 SCSA diagnostics
  44. 8.8.1 SCSA diagnostics Company Information
  45. 8.8.2 SCSA diagnostics Business Overview
  46. 8.8.3 SCSA diagnostics Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  47. 8.8.4 SCSA diagnostics Male Infertility Treatment Product Portfolio
  48. 8.8.5 SCSA diagnostics Recent Developments
  49. 8.9 Merck Serono
  50. 8.9.1 Merck Serono Company Information
  51. 8.9.2 Merck Serono Business Overview
  52. 8.9.3 Merck Serono Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merck Serono Male Infertility Treatment Product Portfolio
  54. 8.9.5 Merck Serono Recent Developments
  55. 8.10 Intas Pharma
  56. 8.10.1 Intas Pharma Company Information
  57. 8.10.2 Intas Pharma Business Overview
  58. 8.10.3 Intas Pharma Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Intas Pharma Male Infertility Treatment Product Portfolio
  60. 8.10.5 Intas Pharma Recent Developments
  61. 8.11 Intas Biopharmaceuticals
  62. 8.11.1 Intas Biopharmaceuticals Company Information
  63. 8.11.2 Intas Biopharmaceuticals Business Overview
  64. 8.11.3 Intas Biopharmaceuticals Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Intas Biopharmaceuticals Male Infertility Treatment Product Portfolio
  66. 8.11.5 Intas Biopharmaceuticals Recent Developments
  67. 8.12 Halotech DNA
  68. 8.12.1 Halotech DNA Company Information
  69. 8.12.2 Halotech DNA Business Overview
  70. 8.12.3 Halotech DNA Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Halotech DNA Male Infertility Treatment Product Portfolio
  72. 8.12.5 Halotech DNA Recent Developments
  73. 8.13 Cadila
  74. 8.13.1 Cadila Company Information
  75. 8.13.2 Cadila Business Overview
  76. 8.13.3 Cadila Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cadila Male Infertility Treatment Product Portfolio
  78. 8.13.5 Cadila Recent Developments
  79. 8.14 Aytu BioScience
  80. 8.14.1 Aytu BioScience Company Information
  81. 8.14.2 Aytu BioScience Business Overview
  82. 8.14.3 Aytu BioScience Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Aytu BioScience Male Infertility Treatment Product Portfolio
  84. 8.14.5 Aytu BioScience Recent Developments
  85. 8.15 ASKA Pharmaceutical Co., Ltd.
  86. 8.15.1 ASKA Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 ASKA Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 ASKA Pharmaceutical Co., Ltd. Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  89. 8.15.4 ASKA Pharmaceutical Co., Ltd. Male Infertility Treatment Product Portfolio
  90. 8.15.5 ASKA Pharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Andrology Solutions
  92. 8.16.1 Andrology Solutions Company Information
  93. 8.16.2 Andrology Solutions Business Overview
  94. 8.16.3 Andrology Solutions Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Andrology Solutions Male Infertility Treatment Product Portfolio
  96. 8.16.5 Andrology Solutions Recent Developments
  97. 8.17 Abeona Therapeutics Inc.
  98. 8.17.1 Abeona Therapeutics Inc. Company Information
  99. 8.17.2 Abeona Therapeutics Inc. Business Overview
  100. 8.17.3 Abeona Therapeutics Inc. Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Abeona Therapeutics Inc. Male Infertility Treatment Product Portfolio
  102. 8.17.5 Abeona Therapeutics Inc. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst